Source: Annual Congress 2007 - Pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Ramasubbu, Z. Safdar, A. Frost (Houston, TX, United States Of America). Pulmonary hypertension (PH) in end-stage renal (ESRD) patients receiving dialysis: prevalence and clinical significance. Eur Respir J 2007; 30: Suppl. 51, 2091

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary arterial hypertension (PAH) among end state renal disease (ESRD) patients under chronic hemodyalisis (HD) Source: Eur Respir J 2007; 30: Suppl. 51, 345s Year: 2007 Pulmonary dysfunctions in end stage chronic renal failure (ESCRF) children on regular hemodialysis: possible risk factors Source: Annual Congress 2007 - Paediatric respiratory physiology in health and disease Year: 2007 Pulmonary hypertension (PH) in chronic hemodialysis (CHD) patients is associated with inflammatory markers and volume overload Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Frequency and features of formation of chronic kidney disease (CKD) in patients with chronic obstructive pulmonary disease. Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Pulmonary function in patients with end-stage renal disease and renal transplant recipients Source: Eur Respir J 2004; 24: Suppl. 48, 56s Year: 2004 Pulmonary hypertension in end-stage renal disease and post renal transplantation patients Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Pulmonary arterial hypertension in patients with chronic kidney disease on dialysis and without dialysis: Results of the PEPPER-study Source: Annual Congress 2011 - Clinical features of human pulmonary hypertension Year: 2011 Lung function in patients with chronic renal failure (CRF) Source: Eur Respir J 2004; 24: Suppl. 48, 222s Year: 2004 Increased prevalence of obstructive airways disease (OAD) in patients with ischemic heart disease (IHD) and hypertension (HT) Source: Eur Respir J 2007; 30: Suppl. 51, 122s Year: 2007 Pleuro-pulmonary changes in patients suffering from end-stage renal disease receiving regular hemodialysis Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases Year: 2011 Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Impact of the duration of renal replacement therapy on the respiratory complications in patients with end-stage renal disease Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Impact of borderline (BL) pulmonary hypertension (PH) in chronic lung diseases (CLD). Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Incorporating patients with chronic heart failure (CHF) into pulmonary rehabilitation (PR): a propensity matched analysis Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020 Chronic obstructive pulmonary disease assessment test (CAT) in patients with COPD, chronic heart failure (CHF), and both Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 The association of diuretics treatment with hospitalization rates of patients with chronic obstructive pulmonary disease and pulmonary hypertension: a population-based study Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Relationship between pulmonary hypertension (PH) and lung function in severe COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 252s Year: 2001 The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD treatment Year: 2013 Prevalence of pulmonary hypertension in patients undergo hemodialysis Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012 Survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Eur Respir J 2005; 26: Suppl. 49, 272s Year: 2005